Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
We got you
They address the metabolic dysfunction that drives type 2 diabetes in ways that insulin alone cannot
Novo Nordisk initially developed the first GLP-1 RA, liraglutide, as a type-2 diabetes treatment
SW, SJ, TM, JW, SH, JT, PT, and SC contributed to the data acquisition and data analysis, and interpretation
Key Metabolic Challenges: Chronic stress, poor diet, and toxins disrupt gut microbiome, leading to inflammation and metabolic dysfunction
US$ 23.61
US$ 20.15
US$ 27.62
US$ 21.97
US$ 21.14
US$ 29.90
US$ 24.45
US$ 23.90
US$ 24.67
US$ 29.09
